{"trial_id": "NCT00243165", "mcode_elements": {"extracted_entities": [], "mcode_mappings": [{"element_type": "ResearchStudy", "code": "randomized", "display": "Randomized allocation", "system": "http://hl7.org/fhir/research-study-classification", "confidence_score": 1.0, "evidence_text": "\"allocation\": \"RANDOMIZED\""}, {"element_type": "ResearchStudy", "code": "parallel", "display": "Parallel assignment", "system": "http://hl7.org/fhir/research-study-classification", "confidence_score": 1.0, "evidence_text": "\"interventionModel\": \"PARALLEL\""}, {"element_type": "ResearchStudy", "code": "prevention", "display": "Prevention", "system": "http://hl7.org/fhir/research-study-classification", "confidence_score": 1.0, "evidence_text": "\"primaryPurpose\": \"PREVENTION\""}, {"element_type": "ResearchStudy", "code": "double-blind", "display": "Double blind", "system": "http://hl7.org/fhir/research-study-classification", "confidence_score": 1.0, "evidence_text": "\"masking\": \"DOUBLE\""}, {"element_type": "CancerCondition", "code": "254837009", "display": "Malignant neoplasm of breast", "system": "SNOMED CT", "confidence_score": 1.0, "evidence_text": "Breast Cancer"}, {"element_type": "CancerCondition", "code": "254837009", "display": "Malignant neoplasm of breast", "system": "SNOMED CT", "confidence_score": 1.0, "evidence_text": "breast cancer patient"}, {"element_type": "CancerRelatedMedicationAdministration", "code": "367372000", "display": "Adjuvant chemotherapy", "system": "SNOMED CT", "confidence_score": 1.0, "evidence_text": "treated with adjuvant chemotherapy"}, {"element_type": "ECOGPerformanceStatus", "code": "LA9624-7", "display": "ECOG Performance Status", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "PS = 2 or less"}, {"element_type": "Patient", "code": "30525-0", "display": "Age", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "minimumAge: 18 Years"}, {"element_type": "CancerCondition", "code": "C4872", "display": "Early Breast Cancer", "system": "NCI Thesaurus", "confidence_score": 1.0, "evidence_text": "early breast cancer"}, {"element_type": "CancerRelatedMedication", "code": "L01DB01", "display": "Doxorubicin", "system": "WHO ATC", "confidence_score": 1.0, "evidence_text": "adriamycin"}, {"element_type": "CancerRelatedMedication", "code": "L01AA01", "display": "Cyclophosphamide", "system": "WHO ATC", "confidence_score": 1.0, "evidence_text": "cyclophosphamide"}, {"element_type": "CancerRelatedMedication", "code": "L01BC02", "display": "Fluorouracil", "system": "WHO ATC", "confidence_score": 1.0, "evidence_text": "5- fluorouracil"}, {"element_type": "CancerRelatedMedication", "code": "V03AF10", "display": "Honey", "system": "WHO ATC", "confidence_score": 1.0, "evidence_text": "Lifemel honey or regular honey"}, {"element_type": "ResearchStudy", "code": "LA33-6", "display": "Clinical trial", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "This study will include 60 patients"}, {"element_type": "ResearchStudy", "code": "LA6683-6", "display": "Double blind procedure", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "double blind"}, {"element_type": "LaboratoryResult", "code": "26464-8", "display": "Leukocytes [#/volume] in Blood", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "WBC count"}, {"element_type": "ResearchStudy", "code": "clinical-trial", "display": "Clinical Trial", "system": "http://hl7.org/fhir/resource-types", "confidence_score": 1.0, "evidence_text": "briefTitle: Lifemel Honey to Reduce Leucopenia During Chemotherapy"}, {"element_type": "ResearchStudy", "code": "clinical-trial", "display": "Clinical Trial", "system": "http://hl7.org/fhir/resource-types", "confidence_score": 1.0, "evidence_text": "officialTitle: Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia"}, {"element_type": "ResearchStudy", "code": "NCT00243165", "display": "NCT00243165", "system": "http://clinicaltrials.gov", "confidence_score": 1.0, "evidence_text": "nctId: NCT00243165"}, {"element_type": "CancerCondition", "code": "254837009", "display": "Malignant neoplasm of breast", "system": "http://snomed.info/sct", "confidence_score": 1.0, "evidence_text": "Breast Cancer Patients"}, {"element_type": "CancerRelatedMedicationAdministration", "code": "367336001", "display": "Chemotherapy", "system": "http://snomed.info/sct", "confidence_score": 1.0, "evidence_text": "Chemotherapy"}, {"element_type": "CancerRelatedMedicationAdministration", "code": "71388002", "display": "Procedure", "system": "http://snomed.info/sct", "confidence_score": 1.0, "evidence_text": "Adjuvant Chemotherapy"}, {"element_type": "CancerRelatedMedicationAdministration", "code": "71388002", "display": "Procedure", "system": "http://snomed.info/sct", "confidence_score": 1.0, "evidence_text": "During Adjuvant Chemotherapy"}, {"element_type": "Observation", "code": "33765-9", "display": "Leukocytes [#/volume] in Blood", "system": "http://loinc.org", "confidence_score": 1.0, "evidence_text": "Leucopenia"}], "source_references": [], "validation_results": "compliance_score=0.3333333333333333 validation_errors=[] validation_warnings=[] required_elements_present=[] missing_elements=[]", "metadata": "engine_type='LLM' entities_count=0 mapped_count=25 processing_time_seconds=None model_used='deepseek-chat' prompt_used='direct_mcode_evidence_based' token_usage=None", "token_usage": null, "error": null}, "original_trial_data": {"protocolSection": {"identificationModule": {"nctId": "NCT00243165", "orgStudyIdInfo": {"id": "LifemelCTIL"}, "organization": {"fullName": "Rambam Health Care Campus", "class": "OTHER"}, "briefTitle": "Lifemel Honey to Reduce Leucopenia During Chemotherapy", "officialTitle": "Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia"}, "statusModule": {"statusVerifiedDate": "2005-10", "overallStatus": "UNKNOWN", "lastKnownStatus": "NOT_YET_RECRUITING", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2005-11"}, "studyFirstSubmitDate": "2005-10-20", "studyFirstSubmitQcDate": "2005-10-20", "studyFirstPostDateStruct": {"date": "2005-10-21", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2009-12-04", "lastUpdatePostDateStruct": {"date": "2009-12-07", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"leadSponsor": {"name": "Rambam Health Care Campus", "class": "OTHER"}, "collaborators": [{"name": "Zuf Globus Laboratories Ltd.", "class": "OTHER"}]}, "descriptionModule": {"briefSummary": "This study will include 60 patients with early breast cancer referred to receive adjuvant chemotherapy with AC ( adriamycin- cyclophosphamide) or CAF ( adriamycin- cyclophosphamide- 5- fluorouracil ) combinations. These patients will receive every day one spoon of Lifemel honey or regular honey ( double blind)- during the adjuvant chemotherapy .Every week a WBC count will be performed in order to record the influence of Lifemel on myelotoxicity."}, "conditionsModule": {"conditions": ["Breast Cancer"], "keywords": ["breast cancer", "honey", "myelosuppression", "chemotherapy"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "PREVENTION", "maskingInfo": {"masking": "DOUBLE"}}, "enrollmentInfo": {"count": 60, "type": "ESTIMATED"}}, "armsInterventionsModule": {"interventions": [{"type": "BEHAVIORAL", "name": "Lifemel honey intake every day"}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Prevention of myelotoxicity-every week during chemotherapy."}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer patient treated with adjuvant chemotherapy\n* PS = 2 or less\n\nExclusion Criteria:\n\n* none", "healthyVolunteers": false, "sex": "FEMALE", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"centralContacts": [{"name": "Georgeta Fried, MD", "role": "CONTACT", "phone": "972-4-8543018", "email": "g_fried@rambam.health.gov.il"}], "overallOfficials": [{"name": "Georgeta Fried, MD", "affiliation": "Rambam Health Care Campus", "role": "PRINCIPAL_INVESTIGATOR"}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2025-09-19"}, "conditionBrowseModule": {"meshes": [{"id": "D001943", "term": "Breast Neoplasms"}], "ancestors": [{"id": "D009371", "term": "Neoplasms by Site"}, {"id": "D009369", "term": "Neoplasms"}, {"id": "D001941", "term": "Breast Diseases"}, {"id": "D012871", "term": "Skin Diseases"}, {"id": "D017437", "term": "Skin and Connective Tissue Diseases"}]}}, "hasResults": false, "McodeResults": {"extracted_entities": [], "mcode_mappings": [{"element_type": "ResearchStudy", "code": "randomized", "display": "Randomized allocation", "system": "http://hl7.org/fhir/research-study-classification", "confidence_score": 1.0, "evidence_text": "\"allocation\": \"RANDOMIZED\""}, {"element_type": "ResearchStudy", "code": "parallel", "display": "Parallel assignment", "system": "http://hl7.org/fhir/research-study-classification", "confidence_score": 1.0, "evidence_text": "\"interventionModel\": \"PARALLEL\""}, {"element_type": "ResearchStudy", "code": "prevention", "display": "Prevention", "system": "http://hl7.org/fhir/research-study-classification", "confidence_score": 1.0, "evidence_text": "\"primaryPurpose\": \"PREVENTION\""}, {"element_type": "ResearchStudy", "code": "double-blind", "display": "Double blind", "system": "http://hl7.org/fhir/research-study-classification", "confidence_score": 1.0, "evidence_text": "\"masking\": \"DOUBLE\""}, {"element_type": "CancerCondition", "code": "254837009", "display": "Malignant neoplasm of breast", "system": "SNOMED CT", "confidence_score": 1.0, "evidence_text": "Breast Cancer"}, {"element_type": "CancerCondition", "code": "254837009", "display": "Malignant neoplasm of breast", "system": "SNOMED CT", "confidence_score": 1.0, "evidence_text": "breast cancer patient"}, {"element_type": "CancerRelatedMedicationAdministration", "code": "367372000", "display": "Adjuvant chemotherapy", "system": "SNOMED CT", "confidence_score": 1.0, "evidence_text": "treated with adjuvant chemotherapy"}, {"element_type": "ECOGPerformanceStatus", "code": "LA9624-7", "display": "ECOG Performance Status", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "PS = 2 or less"}, {"element_type": "Patient", "code": "30525-0", "display": "Age", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "minimumAge: 18 Years"}, {"element_type": "CancerCondition", "code": "C4872", "display": "Early Breast Cancer", "system": "NCI Thesaurus", "confidence_score": 1.0, "evidence_text": "early breast cancer"}, {"element_type": "CancerRelatedMedication", "code": "L01DB01", "display": "Doxorubicin", "system": "WHO ATC", "confidence_score": 1.0, "evidence_text": "adriamycin"}, {"element_type": "CancerRelatedMedication", "code": "L01AA01", "display": "Cyclophosphamide", "system": "WHO ATC", "confidence_score": 1.0, "evidence_text": "cyclophosphamide"}, {"element_type": "CancerRelatedMedication", "code": "L01BC02", "display": "Fluorouracil", "system": "WHO ATC", "confidence_score": 1.0, "evidence_text": "5- fluorouracil"}, {"element_type": "CancerRelatedMedication", "code": "V03AF10", "display": "Honey", "system": "WHO ATC", "confidence_score": 1.0, "evidence_text": "Lifemel honey or regular honey"}, {"element_type": "ResearchStudy", "code": "LA33-6", "display": "Clinical trial", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "This study will include 60 patients"}, {"element_type": "ResearchStudy", "code": "LA6683-6", "display": "Double blind procedure", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "double blind"}, {"element_type": "LaboratoryResult", "code": "26464-8", "display": "Leukocytes [#/volume] in Blood", "system": "LOINC", "confidence_score": 1.0, "evidence_text": "WBC count"}, {"element_type": "ResearchStudy", "code": "clinical-trial", "display": "Clinical Trial", "system": "http://hl7.org/fhir/resource-types", "confidence_score": 1.0, "evidence_text": "briefTitle: Lifemel Honey to Reduce Leucopenia During Chemotherapy"}, {"element_type": "ResearchStudy", "code": "clinical-trial", "display": "Clinical Trial", "system": "http://hl7.org/fhir/resource-types", "confidence_score": 1.0, "evidence_text": "officialTitle: Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia"}, {"element_type": "ResearchStudy", "code": "NCT00243165", "display": "NCT00243165", "system": "http://clinicaltrials.gov", "confidence_score": 1.0, "evidence_text": "nctId: NCT00243165"}, {"element_type": "CancerCondition", "code": "254837009", "display": "Malignant neoplasm of breast", "system": "http://snomed.info/sct", "confidence_score": 1.0, "evidence_text": "Breast Cancer Patients"}, {"element_type": "CancerRelatedMedicationAdministration", "code": "367336001", "display": "Chemotherapy", "system": "http://snomed.info/sct", "confidence_score": 1.0, "evidence_text": "Chemotherapy"}, {"element_type": "CancerRelatedMedicationAdministration", "code": "71388002", "display": "Procedure", "system": "http://snomed.info/sct", "confidence_score": 1.0, "evidence_text": "Adjuvant Chemotherapy"}, {"element_type": "CancerRelatedMedicationAdministration", "code": "71388002", "display": "Procedure", "system": "http://snomed.info/sct", "confidence_score": 1.0, "evidence_text": "During Adjuvant Chemotherapy"}, {"element_type": "Observation", "code": "33765-9", "display": "Leukocytes [#/volume] in Blood", "system": "http://loinc.org", "confidence_score": 1.0, "evidence_text": "Leucopenia"}], "source_references": [], "validation_results": "compliance_score=0.3333333333333333 validation_errors=[] validation_warnings=[] required_elements_present=[] missing_elements=[]", "metadata": "engine_type='LLM' entities_count=0 mapped_count=25 processing_time_seconds=None model_used='deepseek-chat' prompt_used='direct_mcode_evidence_based' token_usage=None", "token_usage": null, "error": null}}}
